retatrutide creator Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam Understanding Retatrutide: Safety and Risks
Description
Manza, P
Detailed analysis from Grandview Research provides comprehensive data on these international trends

Hepatic Fat and MASH Research: Glucagon receptor activation promotes lipolysis and fatty acid oxidation in the liver, reducing hepatic fat content
However, its important to note that using Semaglutide GLP-1 for weight loss in individuals with a BMI below 27 is not currently supported by clinical data or FDA approval

This dual action reduces appetite and slows gastric emptying (the rate at which food leaves your stomach) more effectively than medications that mimic GLP-1 alone